In two patients with JAK2V617F and TET2 mutation(s) at ET (UPN6 and UPN7), JAK2V617F mutation was not detected or detected at low VAF (9.9%) in transformed AML cells; instead VAFs of TET2 mutation were detected at almost same or increased level compared with ET. Here, TET2 is linked to acute myeloid leukemia.